NDLI: Gender Issues in the Pharmacotherapy of Opioid-Addicted Women: Buprenorphine

Please wait, while we are loading the content...

Gender Issues in the Pharmacotherapy of Opioid-Addicted Women: Buprenorphine

Content Provider	Scilit
Author	Unger, Annemarie Jung, Erika Winklbaur, Bernadette Fischer, Gabriele
Copyright Year	2010
Description	Gender, a biological determinant of mental health and illness, plays a critical role in determining patients' susceptibility, exposure to mental health risks, and related outcomes. Regarding sex differences in the epidemiology of opioid dependence, one third of the patients are women of childbearing age. Women have an earlier age of initiation of substance use and a more rapid progression to drug involvement and dependence than men. Generally few studies exist which focus on the special needs of women in opioid maintenance therapy. The aim of this paper is to provide an overview of treatment options for opioid-dependent women, with a special focus on buprenorphine, and to look at recent findings related to other factors that should be taken into consideration in optimizing the treatment of opioid-dependent women. Issues addressed include the role of gender in the choice of medication assisted treatment, sex differences in pharmacodynamics and pharmacokinetics of buprenorphine drug interactions, cardiac interactions, induction of buprenorphine in pregnant patients, the neonatal abstinence syndrome and breastfeeding. This paper aims to heighten the awareness for the need to take gender into consideration when making treatment decisions in an effort to optimize services and enhance the quality of life of women suffering from substance abuse.
Related Links	http://europepmc.org/articles/pmc2858865?pdf=render https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858865/pdf
Ending Page	230
Page Count	14
Starting Page	217
ISSN	10550887
e-ISSN	15450848
DOI	10.1080/10550881003684814
Journal	Journal of addictive diseases
Issue Number	2
Volume Number	29
Language	English
Publisher	Informa UK Limited
Publisher Date	2010-04-16
Access Restriction	Open
Subject Keyword	Womens Studies Gender Buprenorphine Opioid Dependence Neonatal Abstinence Syndrome
Content Type	Text
Resource Type	Article
Subject	Clinical Psychology Psychiatry and Mental Health

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Gender issues in the Pharmacotherapy of Opioid-Addicted Women: Buprenorphine

Naltrexone Treatment for Pregnant Women With Opioid Use Disorder Compared With Matched Buprenorphine Control Subjects

Gender Differences Among In- and Out-of-Treatment Opioid-Addicted Individuals

Methadone Versus Buprenorphine for Opioid Use Dependence and Risk of Neonatal Abstinence Syndrome

Revised Dose Schema of Sublingual Buprenorphine in the Treatment of the Neonatal Opioid Abstinence Syndrome

Opioid Addiction/Pregnancy and Neonatal Abstinence Syndrome (NAS): A Preliminary Open-Label Study of Buprenorphine Maintenance and Drug Use Targeted Psychotherapy (DUST) on Cessation of Addictive Drug Use

Pharmacotherapy in the Treatment of Addiction: Methadone

Review of the assessment and management of neonatal abstinence syndrome

Prenatal treatment for opioid dependency: observations from a large inner-city clinic

Gender Issues in the Pharmacotherapy of Opioid-Addicted Women: Buprenorphine

Similar Documents

Gender issues in the Pharmacotherapy of Opioid-Addicted Women: Buprenorphine

Naltrexone Treatment for Pregnant Women With Opioid Use Disorder Compared With Matched Buprenorphine Control Subjects

Gender Differences Among In- and Out-of-Treatment Opioid-Addicted Individuals

Methadone Versus Buprenorphine for Opioid Use Dependence and Risk of Neonatal Abstinence Syndrome

Revised Dose Schema of Sublingual Buprenorphine in the Treatment of the Neonatal Opioid Abstinence Syndrome

Opioid Addiction/Pregnancy and Neonatal Abstinence Syndrome (NAS): A Preliminary Open-Label Study of Buprenorphine Maintenance and Drug Use Targeted Psychotherapy (DUST) on Cessation of Addictive Drug Use

Pharmacotherapy in the Treatment of Addiction: Methadone

Review of the assessment and management of neonatal abstinence syndrome

Prenatal treatment for opioid dependency: observations from a large inner-city clinic

Gender Issues in the Pharmacotherapy of Opioid-Addicted Women: Buprenorphine